Literature DB >> 16143556

Niemann-Pick type C disease: novel NPC1 mutations and characterization of the concomitant acid sphingomyelinase deficiency.

Hiroaki Tamura1, Tsutomu Takahashi, Nobuhiro Ban, Hiroyuki Torisu, Haruaki Ninomiya, Goro Takada, Nobuya Inagaki.   

Abstract

Niemann-Pick type C (NPC) disease is an inherited lipid storage disorder characterized by the lysosomal accumulation of free cholesterol in affected cells. Three novel mutations in the NPC1 gene (c.3615delA, c.2000C > T, and c.2240delT) were detected in two unrelated patients with the severe phenotype of NPC. The analyses showed that the c.2240delT mutation, which causes a premature stop at codon 748, resulted in nonsense-mediated decay of the mutant transcripts. Immunoblotting analyses for the NPC1 protein did not detect the mutant proteins in COS-1 cells transiently transfected with the two mutant NPC1 cDNA constructs (c.3615delA and c.2000C > T). In NPC cells, sphingomyelin accumulates with cholesterol, leading to an identical subcellular distribution of both lipids. Acid sphingomyelinase (ASM), which is responsible for the lysosomal hydrolysis of sphingomyelin, is partially reduced in NPC fibroblasts. Therefore, NPC fibroblasts were studied to determine if ASM activity was perturbed due to the accumulation of cholesterol. However, these studies demonstrated that the subcellular localization of ASM was preserved, suggesting that the high content of lysosomal cholesterol was not responsible for the decreased ASM activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143556     DOI: 10.1016/j.ymgme.2005.07.025

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  9 in total

1.  Niemann-Pick disease type C: analysis of 7 patients.

Authors:  Hui Xiong; Xin-Hua Bao; Yue-Hua Zhang; You-Ning Xu; Jiong Qin; Hui-Ping Shi; Xi-Ru Wu
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

Review 2.  Complex lipid trafficking in Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  J Inherit Metab Dis       Date:  2014-11-26       Impact factor: 4.982

3.  Improvement in lipid and protein trafficking in Niemann-Pick C1 cells by correction of a secondary enzyme defect.

Authors:  Cecilia Devlin; Nina H Pipalia; Xianghai Liao; Edward H Schuchman; Frederick R Maxfield; Ira Tabas
Journal:  Traffic       Date:  2010-02-22       Impact factor: 6.215

4.  Regulation of sterol transport between membranes and NPC2.

Authors:  Zhi Xu; William Farver; Sarala Kodukula; Judith Storch
Journal:  Biochemistry       Date:  2008-09-30       Impact factor: 3.162

Review 5.  The Cerebellum in Niemann-Pick C1 Disease: Mouse Versus Man.

Authors:  Maria Teresa Fiorenza; Piergiorgio La Rosa; Sonia Canterini; Robert P Erickson
Journal:  Cerebellum       Date:  2022-01-18       Impact factor: 3.648

6.  Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease.

Authors:  Rohini Sidhu; Pamela Kell; Dennis J Dietzen; Nicole Y Farhat; An Ngoc Dang Do; Forbes D Porter; Elizabeth Berry-Kravis; Charles H Vite; Janine Reunert; Thorsten Marquardt; Roberto Giugliani; Charles M Lourenço; Olaf Bodamer; Raymond Y Wang; Ellen Plummer; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  Mol Genet Metab       Date:  2020-01-22       Impact factor: 4.204

Review 7.  The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges.

Authors:  Rebecca Jeyaraj; Kirsten McKay Bounford; Nicola Ruth; Carla Lloyd; Fiona MacDonald; Christian J Hendriksz; Ulrich Baumann; Paul Gissen; Deirdre Kelly
Journal:  Genes (Basel)       Date:  2021-11-21       Impact factor: 4.096

8.  Inhibition of GM3 synthase attenuates neuropathology of Niemann-Pick disease Type C. by affecting sphingolipid metabolism.

Authors:  Hyun Lee; Jong Kil Lee; Yong Chul Bae; Song Hyun Yang; Nozomu Okino; Edward H Schuchman; Tadashi Yamashita; Jae-Sung Bae; Hee Kyung Jin
Journal:  Mol Cells       Date:  2014-02-19       Impact factor: 5.034

Review 9.  Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease.

Authors:  Jose Bras; Andrew Singleton; Mark R Cookson; John Hardy
Journal:  FEBS J       Date:  2008-12       Impact factor: 5.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.